Average premiums for both the Medicare Advantage and Medicare Part D prescription drug programs will decrease next year, driven by regulatory reforms and key provisions from the Inflation Reduction ...

The national average bid amount for Part D plans will increase from $64.28 in 2024 to $179.45 in 2025, according to information released Monday by the Centers for Medicare and Medicaid Services. The ...

On April 23, 2024, the Centers for Medicare & Medicaid Services (CMS) published final rules setting forth Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Program for ...

The Centers for Medicare & Medicaid Services (CMS) updated its guidance on the Inflation Reduction Act of 2022’s (P.L. 117-169) (IRA) Medicare Prescription Payment Plan (M3P) with its release of the ...

Medicare's open enrollment window opens in a few weeks, and the Centers for Medicare & Medicaid Services (CMS) is offering a broad look at the landscape around Medicare Advantage (MA) and Part D ...

The average monthly bid submitted by insurers for 2026 prescription drug plans increased 33% from last year, according to data released by the CMS. Medicare beneficiaries have two options for ...

WASHINGTON, D.C. — In a rare and assertive regulatory move, the Centers for Medicare & Medicaid Services (CMS) has exercised its statutory authority to reject certain standalone prescription drug plan ...

Shares of Humana (NYSE:HUM), Centene (NYSE:CNC), and CVS Health (NYSE:CVS) gained on Tuesday as Wall Street reacted to Medicare Part D bid information announced by the Centers for Medicare & Medicaid ...